Table 4:
Multivariable models for LOS in NASH and ALD cohorts
NASH | Change in average LOS* | 95% CI | p-value |
---|---|---|---|
Age (per 10 yrs) | 2.85 | (−1.17, 6.86) | 0.16 |
Sex (F vs M) | −1.41 | (−8.67, 5.86) | 0.70 |
MELD Score (per 1 point) | 0.19 | (−0.29, 0.68) | 0.42 |
BMI (per 1 kg/m2) | 0.46 | (−0.09, 1.01) | 0.10 |
Muscle mass (per 1 cm2/m2) | −0.28 | (−0.78, 0.21) | 0.25 |
Myosteatosis (per HU) | 0.10 | (−0.32, 0.52) | 0.65 |
Frailty deficit index (per 0.1 unit) | 2.72 | (−0.01, 5.45) | 0.05 |
ALD | Change in average LOS* | 95% CI | p-value |
Age (per 10 yrs) | 1.43 | (−2.23, 5.09) | 0.44 |
Sex (F vs M) | −3.90 | (−11.19, 3.40) | 0.29 |
MELD Score (per 1 point) | 0.31 | (−0.29, 0.91) | 0.31 |
BMI (per 1 kg/m2) | −0.79 | (−1.62, 0.04) | 0.06 |
Muscle mass (per 1 cm2/m2) | 0.21 | (−0.28, 0.69) | 0.40 |
Myosteatosis (per HU) | −0.35 | (−0.77, 0.07) | 0.10 |
Frailty deficit index (per 0.1 unit) | 1.76 | (−1.18, 4.70) | 0.24 |
The estimated difference in LOS (i.e. for age: For every 10-year increase in age the average LOS increases by 2.85 days and 1.43 days in patients with NASH and ALD, respectively); LOS- length of stay